| Financial Year |
March 31 2023 |
| Monetary Funds |
1,417,777,818.28 |
| Held-for-trading Financial Assets |
1,255,500,373.51 |
| Notes Receivable |
-- |
| Accounts Receivable |
465,421,273.00 |
| Advances to Suppliers |
157,859,526.10 |
| Other Receivables |
41,452,114.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
694,169,795.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,632,563.41 |
| Total Current Assets |
4,144,699,160.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,244,156.29 |
| Investment Properties |
-- |
| Fixed Assetes |
1,298,235,799.75 |
| Under-construction Projects |
173,064,301.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
246,377,526.09 |
| R&D expenses |
-- |
| Goodwill |
230,495,035.58 |
| Long-Term Deferred and Prepaid Expenses |
55,234,881.74 |
| Deferred Income Tax Assets |
32,995,837.49 |
| Other Non-Current Assets |
40,600,098.94 |
| Sub-Total of Non-Current Assets |
2,215,601,404.21 |
| Total Assets |
6,360,300,564.21 |
| Short-Term Loans |
285,183,258.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
92,996,212.34 |
| Accounts Payable |
461,841,634.36 |
| Accounts Received In Advance |
11,557,147.42 |
| Employee Compensation Payable |
32,305,171.97 |
| Taxes Payable |
38,833,568.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,277,352.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,879,175.17 |
| Other Current Liabilities |
490,689.18 |
| Sub-Total of Current Liabilities |
1,054,171,870.84 |
| Long-term Loans |
106,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,731,609.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,767,307.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
272,350,400.73 |
| Total Liabilities |
1,326,522,271.57 |
| Paid-In Capital(Or Share Stock) |
208,487,500.00 |
| Capital Surplus |
3,912,772,237.35 |
| Surplus Reserve |
77,379,787.68 |
| LESS:Treasury Stock |
148,304,645.74 |
| Undistributed Profits |
972,017,647.11 |
| Minority Stockholder's Interest |
11,425,766.24 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,022,352,526.40 |
| Owner's Equity（Stockholder's Equity） |
5,033,778,292.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,360,300,564.21 |
